Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0)

Misako Higashida-Konishi; Keisuke Izumi; Masako Tsukamoto; Hiroaki Ohya; Nozomi Takasugi; Satoshi Hama; Yutaro Hayashi; Mari Ushikubo; Kumiko Akiya; Araki Kazuhiro; Yutaka Okano; Hisaji Oshima

doi:10.1007/s10067-020-05223-z

Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0)

Misako Higashida-Konishi, Keisuke Izumi, Masako Tsukamoto, Hiroaki Ohya, Nozomi Takasugi, Satoshi Hama, Yutaro Hayashi, Mari Ushikubo, Kumiko Akiya, Araki Kazuhiro, Yutaka Okano, Hisaji Oshima

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret that the original published version of the above article contained errors. The authors requested that these be noted.

Original language	English
Pages (from-to)	2495-2498
Number of pages	4
Journal	Clinical Rheumatology
Volume	39
Issue number	8
DOIs	https://doi.org/10.1007/s10067-020-05223-z
Publication status	Published - 2020 Aug 1
Externally published	Yes

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1007/s10067-020-05223-z

Fingerprint

Dive into the research topics of 'Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0)'. Together they form a unique fingerprint.

Cite this

Higashida-Konishi, M., Izumi, K., Tsukamoto, M., Ohya, H., Takasugi, N., Hama, S., Hayashi, Y., Ushikubo, M., Akiya, K., Kazuhiro, A., Okano, Y., & Oshima, H. (2020). Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0). Clinical Rheumatology, 39(8), 2495-2498. https://doi.org/10.1007/s10067-020-05223-z

Correction to : Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0). / Higashida-Konishi, Misako; Izumi, Keisuke; Tsukamoto, Masako et al.

In: Clinical Rheumatology, Vol. 39, No. 8, 01.08.2020, p. 2495-2498.

Research output: Contribution to journal › Comment/debate › peer-review

Higashida-Konishi, M, Izumi, K, Tsukamoto, M, Ohya, H, Takasugi, N, Hama, S, Hayashi, Y, Ushikubo, M, Akiya, K, Kazuhiro, A, Okano, Y & Oshima, H 2020, 'Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0)', Clinical Rheumatology, vol. 39, no. 8, pp. 2495-2498. https://doi.org/10.1007/s10067-020-05223-z

Higashida-Konishi M, Izumi K, Tsukamoto M, Ohya H, Takasugi N, Hama S et al. Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0). Clinical Rheumatology. 2020 Aug 1;39(8):2495-2498. doi: 10.1007/s10067-020-05223-z

Higashida-Konishi, Misako ; Izumi, Keisuke ; Tsukamoto, Masako et al. / Correction to : Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0). In: Clinical Rheumatology. 2020 ; Vol. 39, No. 8. pp. 2495-2498.

@article{48815717ba0741c98b188cdcdab1957a,

title = "Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0)",

abstract = "The authors regret that the original published version of the above article contained errors. The authors requested that these be noted.",

author = "Misako Higashida-Konishi and Keisuke Izumi and Masako Tsukamoto and Hiroaki Ohya and Nozomi Takasugi and Satoshi Hama and Yutaro Hayashi and Mari Ushikubo and Kumiko Akiya and Araki Kazuhiro and Yutaka Okano and Hisaji Oshima",

note = "Publisher Copyright: {\textcopyright} 2020, International League of Associations for Rheumatology (ILAR).",

year = "2020",

month = aug,

day = "1",

doi = "10.1007/s10067-020-05223-z",

language = "English",

volume = "39",

pages = "2495--2498",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

number = "8",

}

TY - JOUR

T1 - Correction to

T2 - Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0)

AU - Higashida-Konishi, Misako

AU - Izumi, Keisuke

AU - Tsukamoto, Masako

AU - Ohya, Hiroaki

AU - Takasugi, Nozomi

AU - Hama, Satoshi

AU - Hayashi, Yutaro

AU - Ushikubo, Mari

AU - Akiya, Kumiko

AU - Kazuhiro, Araki

AU - Okano, Yutaka

AU - Oshima, Hisaji

PY - 2020/8/1

Y1 - 2020/8/1

N2 - The authors regret that the original published version of the above article contained errors. The authors requested that these be noted.

AB - The authors regret that the original published version of the above article contained errors. The authors requested that these be noted.

UR - http://www.scopus.com/inward/record.url?scp=85086771273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086771273&partnerID=8YFLogxK

U2 - 10.1007/s10067-020-05223-z

DO - 10.1007/s10067-020-05223-z

M3 - Comment/debate

C2 - 32572805

AN - SCOPUS:85086771273

SN - 0770-3198

VL - 39

SP - 2495

EP - 2498

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 8

ER -

Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement (Clinical Rheumatology, (2020), 39, 8, (2441-2448), 10.1007/s10067-020-05044-0)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this